August 22, 2006
Glaxo Smith Kline Adds Warning to Drug
Posted at August 22, 2006 8:55 AM in Drug Products
.
According to a published report in the Wall St. Journal, Glaxo Smith Kline became the latest drug manufacturer to add a warning label to its ADHD drug, Dexedrine. The new warning label will include a warning about cardiac risks and psychiatric side effects. The new warning was posted on the FDA website yesterday.
Trackback
You can ping this entry by using http://www.saundersblog.com/cgi-bin/mt/mt-tb.cgi/329 .